Microbiota Transfer Therapy for Adults With Autism Spectrum Disorder (ASD) Who Have Gastrointestinal Disorders

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

January 4, 2018

Primary Completion Date

April 15, 2022

Study Completion Date

December 15, 2024

Conditions
Autism Spectrum DisorderGastrointestinal Disorder
Interventions
DRUG

Vancomycin

Oral vancomycin is administered to reduce pathogenic bacteria.

DRUG

MoviPrep

MoviPrep is given at the end of vancomycin therapy to remove the vancomycin and remaining bacteria prior to administering Full-Spectrum Microbiota

BIOLOGICAL

Full Spectrum Microbiota

Gut bacteria from healthy human donors are administered orally in a pill form

Trial Locations (1)

85287

Arizona State University, Tempe

All Listed Sponsors
lead

Arizona State University

OTHER